William Counter

¹⁷⁷Lu-PSMA SPECT Quantitation at 6 Weeks (Dose 2) Predicts Short Progression-Free Survival for Patients Undergoing¹⁷⁷Lu-PSMA-I&T Therapy

Nikeith John, Sarennya Pathmanandavel, Megan Crumbaker et al. · Journal of Nuclear Medicine · 2022 · 70 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database

Louise Emmett, Nathan Papa, William Counter et al. · Journal of Nuclear Medicine · 2023 · 42 citations · Full text

Medicine, Nuclear Medicine, Radiology +17

Patient outcomes following a response biomarker-guided approach to treatment using 177Lu-PSMA-I&T in men with metastatic castrate-resistant prostate cancer (Re-SPECT)

Louise Emmett, Nikeith John, Sarennya Pathmanandavel et al. · Therapeutic Advances in Medical Oncology · 2023 · 39 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen–Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Score for More Accurate Diagnosis of Clinically Significant Prostate Cancer

Louise Emmett, Nathan Papa, Thomas A. Hope et al. · The Journal of Urology · 2024 · 27 citations · Full text

Medicine, Oncology, Urology +17

Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer patients for focal therapy

Bart Geboers, Dennie Meijer, William Counter et al. · British Journal of Urology · 2023 · 19 citations · Full text

Medicine, Nuclear Medicine, Radiology +17